What is the current Pancreatic Stents market size?

The Pancreatic Stents market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Pancreatic Stents market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Pancreatic Stents market?

Key drivers include rising pancreatic cancer cases and growing adoption of minimally invasive procedures.

What are the major challenges facing the Pancreatic Stents market?

Challenges include high costs, limited reimbursement, and stringent regulatory approvals.

Which regions are expected to lead the Pancreatic Stents market?

North America and Europe are expected to dominate the market due to advanced healthcare infrastructure.

Who are the top companies in the Pancreatic Stents market?

Top companies include Boston Scientific, Cook Medical, and Medtronic, offering a range of stent products.

What future opportunities exist in the Pancreatic Stents market?

Future opportunities include emerging markets, innovative stent designs, and increasing demand for pancreatic cancer treatment.

How will technology impact the Pancreatic Stents market?

Advances in material science and 3D printing will drive innovation, improving stent design and functionality.

What is the current regulatory landscape for the Pancreatic Stents market?

The market is subject to stringent FDA and CE mark regulations, ensuring safety and efficacy of stent products.

What is the future outlook for the Pancreatic Stents market?

The future outlook is positive, with growing demand and advancing technology driving market growth.

Why Is the Pancreatic Stents Market Growing So Fast? 2026 Analysis

Pancreatic Stents by Application (Hospitals, Clinics, Others), by Types (Straight Pancreatic Stents, Wedge Pancreatic Stents, Curved Pancreatic Stents), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1230 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1230 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Pancreatic Stents Market Size | CAGR 7.2 Forecast 2033

Why Is the Pancreatic Stents Market Growing So Fast? 2026 Analysis

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1230 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $1230 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Pancreatic Stents Market Overview

The Pancreatic Stents market refers to the global market for stents used in the treatment of pancreatic diseases, including pancreatic cancer and pancreatitis. As the growth outlook for this market continues to evolve, it is essential to understand the current Pancreatic Stents market size, which is approximately $123.4 million, and the market forecast, which predicts a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033. The industry expansion is driven by increasing demand for minimally invasive procedures, advancements in stent technology, and growing awareness about pancreatic diseases. The scope of this market encompasses various types of stents, including metal, plastic, and biodegradable stents, used in different applications, such as pancreatic duct stenting and common bile duct stenting.

Loading chart…

The Pancreatic Stents market is expected to be shaped by key forces such as technology shifts towards more advanced stent materials and designs, regulations governing the approval and use of medical devices, and competitive intensity among market players. The largest region for this market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing healthcare expenditure and improving healthcare infrastructure. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and developments to make strategic decisions and capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	2.15 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific Corporation; C. R. Bard; Merit Medical Systems, Inc.; Cook Group Incorporated; Becton, Dickinson and Company; Cantel Medical Corporation; Olympus Corporation; ConMed Corporation; ENDO-FLEX GmbH; Diagmed Healthcare Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Pancreatic Stents market is poised for significant growth, driven by increasing demand for minimally invasive procedures and advancements in stent technology. The market dynamics are influenced by various factors, including technological advancements, regulatory approvals, and shifting consumer preferences.

Growth Drivers2 items

Advances in stent design and materials are improving the efficacy and safety of pancreatic stenting procedures, driving the growth of the Pancreatic Stents market size. Additionally, the increasing prevalence of pancreatic cancer and other pancreatic disorders is fueling the demand for stenting procedures.

The growing adoption of endoscopic ultrasound-guided procedures is expanding the application of pancreatic stents, further contributing to the growth forecast of the market. Moreover, the rising awareness about the benefits of minimally invasive procedures is driving patient preference for stenting over traditional surgical methods.

Restraints2 items

The high cost of pancreatic stents and the associated procedures is a significant barrier to adoption, particularly in developing countries with limited healthcare budgets. Furthermore, the lack of standardization in stent design and sizing is affecting the overall efficiency and effectiveness of stenting procedures.

The risk of stent occlusion and other complications is a concern for patients and healthcare providers, which may limit the growth of the Pancreatic Stents market. Additionally, the stringent regulatory requirements for stent approval and commercialization are slowing down the entry of new products into the market.

Opportunities2 items

The increasing focus on developing biodegradable pancreatic stents is creating new opportunities for market players to innovate and differentiate their products. Moreover, the growing demand for stenting procedures in emerging markets is providing opportunities for companies to expand their geographical presence.

The rising adoption of robotic-assisted procedures is expected to drive the demand for advanced stenting systems, including pancreatic stents. Additionally, the growing trend of outsourcing stent manufacturing to contract manufacturers is creating opportunities for companies to optimize their production costs and improve efficiency.

Challenges2 items

The Pancreatic Stents market is highly competitive, with several established players competing for market share. Furthermore, the rapid advancements in stent technology and materials are creating challenges for companies to stay up-to-date with the latest developments and maintain their competitive edge.

The lack of standardization in stent testing and evaluation is affecting the ability of companies to demonstrate the safety and efficacy of their products. Additionally, the evolving regulatory landscape and changing reimbursement policies are creating uncertainty and challenges for market players to navigate.

Market Segmentation

Loading chart…

The Application segment of the Pancreatic Stents market is divided into subtypes, each contributing to the overall market size. This segmentation is crucial for understanding the Pancreatic Stents segmentation and market taxonomy. The application segment includes various medical procedures where pancreatic stents are used, such as drainage of pancreatic pseudocysts, treatment of pancreatic ductal stones, and management of pancreatic fistulas. Each application subtype has a distinct market size and growth rate, influencing the overall Pancreatic Stents market.

The Types segment of the Pancreatic Stents market includes subtypes such as metal stents and plastic stents. Metal stents are further divided into uncovered, partially covered, and fully covered stents. Plastic stents are also divided into subtypes, including single-pigtail stents and double-pigtail stents. Each type of stent has its own market size and growth rate, contributing to the overall Pancreatic Stents market size. Understanding the market taxonomy of these subtypes is essential for analyzing the Pancreatic Stents market.

Pancreatic Stents Segmentation Breakdown8 items

Application

Hospitals

Clinics

Others

Types

Straight Pancreatic Stents

Wedge Pancreatic Stents

Curved Pancreatic Stents

Regional Insights

Loading chart…

The Pancreatic Stents market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: North America, driven by demographics and ecosystem maturity; Europe, driven by adoption and policies; Asia Pacific, driven by infrastructure development and investments; Latin America, driven by adoption and demographics; and Middle East & Africa, driven by infrastructure development and ecosystem maturity. Understanding these regional factors is crucial for regional forecast and market strategy development.

Regional Insights5 items

North America: driven by demographics and ecosystem maturity

Europe: driven by adoption and policies

Asia Pacific: driven by infrastructure development and investments

Latin America: driven by adoption and demographics

Middle East & Africa: driven by infrastructure development and ecosystem maturity

Competitive Landscape

The Pancreatic Stents market exhibits a moderately consolidated structure, with a mix of global players and local companies competing on various fronts, including pricing, distribution, product innovation, certifications, and regulatory approvals. The Pancreatic Stents competitive landscape is characterized by high competition, with companies employing different strategies to gain market share. Global players tend to have an edge in terms of product portfolio and distribution networks, while local companies focus on regional expansion and customization to cater to specific market needs.

Companies in the Pancreatic Stents market employ various strategies to differentiate themselves, such as investing in research and development, forming partnerships, and expanding their product lines. However, they face challenges like margin pressure, compliance costs, and supply chain risks. To stay competitive, companies must focus on innovation, technology, and service model differentiation. The following companies have adopted distinct strategies to stay ahead in the market:

Boston Scientific Corporation: regional expansion

C. R. Bard: premium pricing

Merit Medical Systems, Inc.: innovation pipeline

Cook Group Incorporated: local manufacturing

Becton, Dickinson and Company: OEM tie-ups

Cantel Medical Corporation: vertical integration

Key Pancreatic Stents Companies10 items

Boston Scientific Corporation

C. R. Bard

Merit Medical Systems, Inc.

Cook Group Incorporated

Becton, Dickinson and Company

Cantel Medical Corporation

Olympus Corporation

ConMed Corporation

ENDO-FLEX GmbH

Diagmed Healthcare Ltd.

Market Ecosystem

The Pancreatic Stents ecosystem spans upstream, midstream, and downstream activities, encompassing technology providers, integrators, channels, and end users. This complex network creates and captures value through the development, manufacturing, and distribution of pancreatic stents, ultimately delivering these medical devices to patients. The ecosystem's boundaries are defined by the interactions among these participants, influencing how value flows through the system.

Raw material suppliers — providing stent materials

OEMs / manufacturers — producing pancreatic stents

Distributors / channel partners — delivering stents to healthcare facilities

Service providers / after-sales — offering maintenance and support

End users / buyers — prescribing and using pancreatic stents

Regulators/standards bodies — overseeing safety and efficacy standards

Data/analytics providers — supplying market insights and research

In the Pancreatic Stents ecosystem, control points are primarily held by regulators and end users, as they influence adoption through approval processes and prescribing decisions. Dependency risks arise from input constraints, such as material availability, and standards approvals, which can impact the production and distribution of pancreatic stents. Furthermore, switching costs and partnerships between manufacturers and distributors can affect the ecosystem's dynamics. A thorough value chain analysis is necessary to understand these intricacies and how they vary by region, ultimately shaping the Pancreatic Stents ecosystem.

Recent Industry Insights

The Pancreatic Stents market has witnessed significant developments over the last 12-18 months, shaping the future of Pancreatic Stents industry trends. Recent partnerships between key players have focused on enhancing product portfolios and expanding geographical reach. Notable mergers and acquisitions have also led to increased consolidation in the market, with major companies strengthening their positions through strategic acquisitions. Furthermore, several product and technology launches have improved the efficacy and safety of pancreatic stents, addressing the growing demand for minimally invasive procedures.

Additionally, regulatory changes have played a crucial role in governing the market, with authorities implementing stricter guidelines to ensure the quality and safety of pancreatic stents. A shift in consumer trends towards more advanced and patient-centric treatments has also driven innovation in the industry. Moreover, funding rounds and expansions have enabled companies to invest in research and development, paving the way for future growth and advancements in the Pancreatic Stents industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Pancreatic Stents market outlook. The market attractiveness is moderate, driven by the increasing prevalence of pancreatic diseases and advancements in medical technology. The competitive intensity is high, with key players investing heavily in research and development to improve stent design and functionality. The long-term outlook is promising, with the Pancreatic Stents market expected to grow significantly over the next five years.

The innovation landscape is rapidly evolving, with a focus on developing more effective and minimally invasive stent placement procedures. However, the demand-supply balance is a key concern, with supply chain disruptions and raw material shortages posing significant risks. Other key risk factors include regulatory changes and reimbursement challenges. Overall, the Pancreatic Stents market outlook is favorable, with opportunities for growth and innovation, but also requires careful navigation of the competitive and regulatory landscape.

12 items

1. Executive Summary

2. Pancreatic Stents Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Pancreatic Stents Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Pancreatic Stents Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Pancreatic Stents Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Pancreatic Stents Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Pancreatic Stents Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Pancreatic Stents Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Pancreatic Stents Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Pancreatic Stents Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Pancreatic Stents Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Pancreatic Stents Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Pancreatic Stents Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Pancreatic Stents Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Pancreatic Stents Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Pancreatic Stents Market Competition by Key Manufacturers

9.1. Global Pancreatic Stents Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Pancreatic Stents: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Boston Scientific Corporation

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. C. R. Bard

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Merit Medical Systems, Inc.

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Cook Group Incorporated

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Becton, Dickinson and Company

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Cantel Medical Corporation

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Olympus Corporation

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. ConMed Corporation

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. ENDO-FLEX GmbH

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Diagmed Healthcare Ltd.

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Pancreatic Stents Market

Figure 4: Global Pancreatic Stents Market: Drivers

Figure 5: Global Pancreatic Stents Market: Challenges

Figure 6: Global Pancreatic Stents Market: Trends

Figure 7: Global Pancreatic Stents Market: Opportunity

Figure 8: Global Pancreatic Stents Market: Restraint

Figure 9: Global Pancreatic Stents Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Pancreatic Stents Market Value (USD Million) By Region

Figure 19: Global Pancreatic Stents Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Pancreatic Stents Market Value (USD Million) By Region

Figure 27: Global Pancreatic Stents Market Share (%) By: Regions (2032)

Figure 28: Global Pancreatic Stents Market Volume (K) By Region

Figure 29: Global Pancreatic Stents Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Pancreatic Stents Market Value (USD Million) By Region

Figure 37: Global Pancreatic Stents Market Share (%) By: Regions (2032)

Figure 38: Global Pancreatic Stents Market Volume (K) By Region

Figure 39: Global Pancreatic Stents Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Pancreatic Stents Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Pancreatic Stents Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Pancreatic Stents Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Pancreatic Stents Market Value (USD Million) By Region

Table 14: Global Pancreatic Stents Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Pancreatic Stents Market Volume (K) By Region

Table 31: Global Pancreatic Stents Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Pancreatic Stents Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Pancreatic Stents Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Pancreatic Stents Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Boston Scientific Corporation Basic Information And Sales Area

Table 52: Boston Scientific Corporation. Products Portfolio

Table 53: C. R. Bard Basic Information And Sales Area

Table 54: C. R. Bard. Products Portfolio

Table 55: Merit Medical Systems, Inc. Basic Information And Sales Area

Table 56: Merit Medical Systems, Inc.. Products Portfolio

Table 57: Cook Group Incorporated Basic Information And Sales Area

Table 58: Cook Group Incorporated. Products Portfolio

Table 59: Becton, Dickinson and Company Basic Information And Sales Area

Table 60: Becton, Dickinson and Company. Products Portfolio

Table 61: Cantel Medical Corporation Basic Information And Sales Area

Table 62: Cantel Medical Corporation. Products Portfolio

Table 63: Olympus Corporation Basic Information And Sales Area

Table 64: Olympus Corporation. Products Portfolio

Table 65: ConMed Corporation Basic Information And Sales Area

Table 66: ConMed Corporation. Products Portfolio

Table 67: ENDO-FLEX GmbH Basic Information And Sales Area

Table 68: ENDO-FLEX GmbH. Products Portfolio

Table 69: Diagmed Healthcare Ltd. Basic Information And Sales Area

Table 70: Diagmed Healthcare Ltd.. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Pancreatic Stents Market Value (USD Million) By Region

Table 80: Global Pancreatic Stents Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Pancreatic Stents Market Volume (K) By Region

Table 97: Global Pancreatic Stents Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Pancreatic Stents Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	2.15 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific Corporation; C. R. Bard; Merit Medical Systems, Inc.; Cook Group Incorporated; Becton, Dickinson and Company; Cantel Medical Corporation; Olympus Corporation; ConMed Corporation; ENDO-FLEX GmbH; Diagmed Healthcare Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options